Market closedNon-fractional
STAAR/STAA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About STAAR
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
Ticker
STAA
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Lake Forest, United States
Employees
1,057
Website
www.staar.com
STAAR Metrics
BasicAdvanced
$2B
Market cap
130.52
P/E ratio
$0.31
EPS
0.81
Beta
-
Dividend rate
Price and volume
Market cap
$2B
Beta
0.81
Financial strength
Current ratio
5.835
Quick ratio
4.992
Long term debt to equity
7.924
Total debt to equity
9.088
Management effectiveness
Return on assets (TTM)
3.38%
Return on equity (TTM)
4.18%
Valuation
Price to earnings (TTM)
130.521
Price to revenue (TTM)
6.07
Price to book
5.1
Price to tangible book (TTM)
5.12
Price to free cash flow (TTM)
94.839
Growth
Revenue change (TTM)
10.70%
Earnings per share change (TTM)
-52.77%
3-year revenue growth (CAGR)
22.15%
3-year earnings per share growth (CAGR)
12.21%
What the Analysts think about STAAR
Analyst Ratings
Majority rating from 13 analysts.
STAAR Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$77M
1.44%
Net income
-$3.3M
-142.86%
Profit margin
-4.26%
-142.18%
STAAR Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.40
$0.30
$0.13
-$0.05
-
Expected
$0.19
$0.18
$0.17
$0.05
$0.24
Surprise
107.79%
68.75%
-25.33%
-201.35%
-
STAAR News
AllArticlesVideos
Top 4 Stocks With Notable Insider Buying
MarketBeat·2 months ago
STAAR Surgical Company (STAA) Q1 2024 Earnings Call Transcript
Seeking Alpha·3 months ago
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for STAAR stock?
STAAR (STAA) has a market cap of $2B as of July 27, 2024.
What is the P/E ratio for STAAR stock?
The price to earnings (P/E) ratio for STAAR (STAA) stock is 130.52 as of July 27, 2024.
Does STAAR stock pay dividends?
No, STAAR (STAA) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next STAAR dividend payment date?
STAAR (STAA) stock does not pay dividends to its shareholders.
What is the beta indicator for STAAR?
STAAR (STAA) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell STAAR stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.